Scalper1 News
Medical giant Johnson & Johnson (JNJ) kicked off the industry’s Q3 earnings season on a strong note with a sales and earnings beat early Tuesday, though the stock was down 1% in morning trading on the stock market today. J&J’s earnings, excluding one-time items, rose 10% over the year-earlier quarter to $1.50 a share, beating analysts’ estimates by 5 cents. Sales climbed 5% to $18.47 billion, $90 million ahead of consensus. The company raised its Scalper1 News
Scalper1 News